Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Collister

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 9, 2021
Coming full circle: patient and physician reunite in kidney research networkDavid Collister, Arlene Desjarlais
Clinical Journal of the American Society of Nephrology : CJASN|June 12, 2019
Post-PIVOTAL Iron Dosing with Maintenance HemodialysisDavid Collister, Navdeep Tangri
Annals of Internal Medicine|September 2, 2024
In T2DM with CKD, semaglutide reduced major kidney disease events at 3 yDavid Collister, Neesh Pannu
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 8, 2021
Mineralocorticoid Receptor Antagonists in CKD: In Need of a Few Large TrialsDavid Collister, Michael Walsh
Kidney International Reports|April 30, 2025
Searching for Fire Amid the Smoke: Will Cannabinoids Prove Useful and Safe for Those With CKD?Brendan Smyth, David Collister
Kidney International Reports|June 2, 2018
Conventional Risk Factors Associated With Meaningful Outcomes in Advanced CKDDavid Collister, Navdeep Tangri
The Journal of Clinical Investigation|May 1, 2025
The differential effects of sex hormone therapy on kidney function: insights into biological sex differencesDavid Collister, Adeera Levin
Clinical Journal of the American Society of Nephrology : CJASN|October 23, 2023
Does Gender-Affirming Hormone Therapy Affect the Kidney?David Collister, Sofia B Ahmed
Current Opinion in Nephrology and Hypertension|March 17, 2018
Fracture risk and treatment in chronic kidney diseaseKelsey Connelly, David Collister, Navdeep Tangri
Journal of Clinical Epidemiology|August 21, 2021
Response to Weinfurt and Cappelleri on "Patient reported outcome measures in clinical trials should be initially analyzed as continuous outcomes for statistical significance and responder analyses should be reserved as secondary analyses"David Collister, Shrikant Bangdiwala, Gordon Guyatt
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 9, 2021
Coming full circle: patient and physician reunite in kidney research networkDavid Collister, Arlene Desjarlais
Clinical Journal of the American Society of Nephrology : CJASN|June 12, 2019
Post-PIVOTAL Iron Dosing with Maintenance HemodialysisDavid Collister, Navdeep Tangri
Annals of Internal Medicine|September 2, 2024
In T2DM with CKD, semaglutide reduced major kidney disease events at 3 yDavid Collister, Neesh Pannu
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 8, 2021
Mineralocorticoid Receptor Antagonists in CKD: In Need of a Few Large TrialsDavid Collister, Michael Walsh
Kidney International Reports|April 30, 2025
Searching for Fire Amid the Smoke: Will Cannabinoids Prove Useful and Safe for Those With CKD?Brendan Smyth, David Collister
Kidney International Reports|June 2, 2018
Conventional Risk Factors Associated With Meaningful Outcomes in Advanced CKDDavid Collister, Navdeep Tangri
The Journal of Clinical Investigation|May 1, 2025
The differential effects of sex hormone therapy on kidney function: insights into biological sex differencesDavid Collister, Adeera Levin
Clinical Journal of the American Society of Nephrology : CJASN|October 23, 2023
Does Gender-Affirming Hormone Therapy Affect the Kidney?David Collister, Sofia B Ahmed
Current Opinion in Nephrology and Hypertension|March 17, 2018
Fracture risk and treatment in chronic kidney diseaseKelsey Connelly, David Collister, Navdeep Tangri
Journal of Clinical Epidemiology|August 21, 2021
Response to Weinfurt and Cappelleri on "Patient reported outcome measures in clinical trials should be initially analyzed as continuous outcomes for statistical significance and responder analyses should be reserved as secondary analyses"David Collister, Shrikant Bangdiwala, Gordon Guyatt
Pageof 12